January 22, 2024
2 min watch
Save
VIDEO: Perfluorohexyloctane offers new clinical tool for evaporative dry eye disease
WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Laura M. Periman, MD, discusses innovations in evaporative dry eye disease.
“We now have a clinical tool to address the evaporative load of ocular surface disease in real time. This is perfluorohexyloctane,” she said. “It was studied at four times a day in the clinical trials. Clinically, I’m using it two to four times a day. How I explain it to my patient is, ‘This is like Saran wrap for the fruit salad.’”
Published by:
Sources/Disclosures
Collapse
Source:
Periman LM. Breaking the drought: Diagnosing and treating evaporative dry eye disease. Presented at: Hawaiian Eye 2024; Jan. 13-19, 2024; Wailea, Hawaii.
Disclosures:
Periman reports having financial disclosures for Allergan/AbbVie, Bausch + Lomb and Viatris.